Literature DB >> 2848805

High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP.

J Spychała1, V Madrid-Marina, I H Fox.   

Abstract

A human placental soluble "high Km" 5'-nucleotidase has been separated from "low Km" 5'-nucleotidase and nonspecific phosphatase by AMP-Sepharose affinity chromatography. The enzyme was purified 8000-fold to a specific activity of 25.6 mumol/min/mg. The subunit molecular mass is 53 kDa, and the native molecular mass is 210 kDa, suggesting a tetrameric structure. Soluble high Km 5'-nucleotidase is most active with IMP and GMP and their deoxy derivatives. IMP is hydrolyzed 15 times faster than AMP. The enzyme has a virtually absolute requirement for magnesium ions and is regulated by them. Purine nucleoside 5'-triphosphates strongly activate the enzyme with the potency order dATP greater than ATP greater than GTP. 2,3-Diphosphoglycerate activates the enzyme as potently as ATP. Three millimolar ATP decreased the Km for IMP from 0.33 to 0.09 mM and increased the Vmax 12-fold. ATP activation was modified by the IMP concentration. At 20 microM IMP the ATP-dependent activation curve was sigmoidal, while at 2 mM IMP it was hyperbolic. The A0.5 values for ATP were 2.26 and 0.70 mM, and the relative maximal velocities were 32.9 and 126.0 nmol/min, respectively. Inorganic phosphate shifts the hyperbolic substrate velocity relationship for IMP to a sigmoidal one. With physiological concentrations of cofactors (3 mM ATP, 1-4 mM Pi, 150 mM KCl) at pH 7.4, the enzyme is 25-35 times more active toward 100 microM IMP than 100 microM AMP. These data show that: (a) soluble human placental high Km 5'-nucleotidase coexists in human placenta with the low Km enzyme; (b) under physiological conditions the enzyme favors the hydrolysis of IMP and is critically regulated by IMP, ATP, and Pi levels; and (c) kinetic properties of ATP and IMP are each modified by the other compound suggesting complex interaction of the associated binding sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Developmental disorder associated with increased cellular nucleotidase activity.

Authors:  T Page; A Yu; J Fontanesi; W L Nyhan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

Review 3.  Emerging functional roles for the glycosyl-phosphatidylinositol membrane protein anchor.

Authors:  M P Lisanti; E Rodriguez-Boulan; A R Saltiel
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

Review 4.  Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL.

Authors:  Chelsea L Dieck; Adolfo Ferrando
Journal:  Blood       Date:  2019-03-25       Impact factor: 22.113

5.  Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.

Authors:  Shuji Yamamoto; Takahiro Yamauchi; Yasukazu Kawai; Haruyuki Takemura; Shinji Kishi; Akira Yoshida; Yoshimasa Urasaki; Hiromichi Iwasaki; Takanori Ueda
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

6.  Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells.

Authors:  Veronika Kulikova; Konstantin Shabalin; Kirill Nerinovski; Christian Dölle; Marc Niere; Alexander Yakimov; Philip Redpath; Mikhail Khodorkovskiy; Marie E Migaud; Mathias Ziegler; Andrey Nikiforov
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

7.  Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart.

Authors:  A C Skladanowski; A C Newby
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

8.  Identification, partial purification and inhibition by guanine analogues of a novel enzymic activity which phosphorylates guanosine to GMP in the protozoan parasite Eimeria tenella.

Authors:  G Maga; S Spadari; G E Wright; F Focher
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

9.  NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Authors:  Yin Lu; Paul A Rosenberg
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

10.  Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia.

Authors:  Chelsea L Dieck; Gannie Tzoneva; Farhad Forouhar; Zachary Carpenter; Alberto Ambesi-Impiombato; Marta Sánchez-Martín; Renate Kirschner-Schwabe; Scott Lew; Jayaraman Seetharaman; Liang Tong; Adolfo A Ferrando
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.